Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.81 USD | -48.72% | -.--% | -.--% |
Mar. 19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
Mar. 19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
Chart calendar SanBio Company Limited
Upcoming events on SanBio Company Limited
Past events on SanBio Company Limited
2024-03-18 | Q4 2023 Earnings Call |
2024-03-17 | Q4 2023 Earnings Release |
2023-12-13 | Q3 2023 Earnings Release |
2023-09-13 | Q2 2023 Earnings Release |
2023-06-13 | Q1 2023 Earnings Release |
2023-04-25 | Annual General Meeting |
2023-03-15 | Q4 2022 Earnings Release |
2022-12-14 | Q3 2023 Earnings Release |
2022-06-13 | Q1 2022 Earnings Release |
2022-04-05 12:15 pm | American Academy of Neurology Meeting |
2022-03-10 | FY 2021 Earnings Call |
2022-03-10 | FY 2021 Earnings Release |
2021-12-14 | Q3 2021 Earnings Release |
2021-09-13 | Interim 2021 Earnings Release |
2021-06-13 | Q1 2021 Earnings Release |
2021-03-16 | FY 2020 Earnings Release |
2020-12-14 | Q3 2020 Earnings Release |
2020-09-13 | Interim 2020 Earnings Release |
2020-06-11 | Q1 2020 Earnings Release |
2020-04-27 | Annual General Meeting |
Annual results
Fiscal Period | January | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 447 444 0.68% | 0,00 403 - | 0,00 0,00 - | 0,00 219 - | 0,00 0,00 - | 0,00 |
EBITDA Million JPY | Released Forecast Spread | -5 446 -4 831 -12.74% | -5 727 -5 911 3.11% | -6 488 -6 332 -2.47% | -7 875 -7 851 -0.3% | -4 525 -4 480 -1.02% | -3 106 |
EBIT Million JPY | Released Forecast Spread | -5 486 -5 083 -7.94% | -5 802 -6 023 3.67% | -6 620 -6 589 -0.47% | -7 899 -7 444 -6.12% | -4 540 -5 176 12.3% | -4 040 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -5 157 -4 605 -11.98% | -3 211 -6 669 51.84% | -4 560 -4 515 -1% | -4 697 -4 046 -16.09% | -2 542 -3 731 31.87% | -3 532 |
Net income Million JPY | Released Forecast Spread | -5 158 -4 607 -11.96% | -3 386 -6 133 44.8% | -4 677 -4 617 -1.3% | -5 559 -5 076 -9.52% | -2 644 -4 079 35.16% | -3 295 |
EPS JPY | Released Forecast Spread | -101 -90,7 -11.27% | -65,4 -119 44.92% | -90,3 -89,2 -1.31% | -96,0 -89,1 -7.76% | -40,5 -63,1 35.89% | -49,1 |
Announcement Date | 16/03/20 | 17/03/21 | 11/03/22 | 16/03/23 | 18/03/24 | - |
Quarterly results
Fiscal Period | January | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 19,5 22,0 -11.55% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 875 - | 0,00 174 - | 0,00 349 - | 0,00 523 - | 0,00 523 - | 698 | ||
EBIT Million JPY | Released Forecast Spread | -3 101 -2 715 -14.21% | -2 570 | -3 232 -3 129 -3.28% | -3 052 | -1 844 -1 400 -31.71% | -2 778 -1 317 -110.93% | -4 622 -3 161 -46.22% | -1 783 -1 427 -24.95% | -1 494 -530 -181.9% | -1 461 -1 746 16.32% | -1 623 -1 104 -47.02% | -3 085 -2 850 -8.24% | -640 -1 092 41.36% | -814 -703 -15.75% |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -3 109 -2 553 -21.79% | -3 205 | -6,00 -2 593 99.77% | -2 127 | 869 | -774 | 1 211 | -866 | -1 858 | 116 | ||||
Net income Million JPY | Released Forecast Spread | -3 109 -2 551 -21.87% | -3 207 | -179 -2 593 93.1% | -2 134 | -315 | -2 154 | 396 | -626 | -1 787 | -96,0 | ||||
EPS JPY | Released Forecast Spread | -61,9 | -41,2 | -5,98 | -39,3 | 8,14 | -9,68 | -27,6 | -1,40 | ||||||
Announcement Date | 16/03/20 | 14/09/20 | 17/03/21 | 14/09/21 | 14/06/22 | 14/09/22 | 14/09/22 | 15/12/22 | 16/03/23 | 14/06/23 | 14/09/23 | 14/09/23 | 14/12/23 | 18/03/24 |
Past sector events for SanBio Company Limited
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4592 Stock
- SNBOY Stock
- Calendar SanBio Company Limited